- Employee representatives elected for a four-year term are Semsi Kilic Madsen, Mette Bøjer Jensen, Elisabeth Dahl Christensen, and Désirée Jantzen Asgreen.
- Substitutes elected are Trine Hartvig Kristiansen, Tamara Schmidt, Tanja Villumsen, and Hassan Kassem.
- New representatives join the Board after the annual general meeting on 26 March 2026.
- Liselotte Hyveled and Tanja Villumsen will resign from the Board.
Election Results
On 2 March 2026, Novo Nordisk A/S employees completed the election of their representatives to the Board of Directors. The elected representatives for the next four years are Semsi Kilic Madsen and Désirée Jantzen Asgreen, who are new to the board, and Mette Bøjer Jensen and Elisabeth Dahl Christensen, who have been re-elected.
Substitute Members
In addition to the primary representatives, four substitutes were elected: Trine Hartvig Kristiansen, Tamara Schmidt, Tanja Villumsen, and Hassan Kassem. These substitutes will step in if any of the primary representatives are unable to fulfill their duties.
Transition Timeline
The newly elected employee representatives will officially join the Board of Directors following the annual general meeting of Novo Nordisk A/S, scheduled for 26 March 2026. At this time, current board members Liselotte Hyveled and Tanja Villumsen, who did not seek re-election, will resign from their positions.
Employee Representation
According to the Danish Companies Act, employees of Novo Nordisk A/S are entitled to representation on the Board of Directors, with employee-elected members making up half of the total shareholder-elected board members. These representatives serve a statutory four-year term and hold the same rights, duties, and responsibilities as their shareholder-elected counterparts.
